Latest Share Chat

REMOVE ADS

Shire Share News (SHP)

Shire Information

There is currently no data for SHP

REMOVE ADS

Shire News

Shire And Kamada Get Expanded Label Approval For Glassia

Shire buys bowel disease drug rights from Pfizer

(ShareCast News) - Shire has agreed to buy the rights to an experimental drug aimed at treating inflammatory bowel disease (IBD) from Pfizer. The PF-0...

Shire wins FDA breakthrough therapy designation for two drugs

(ShareCast News) - Shire has been given an encouraging green light by the US drug regulator for two potential rare disease treatments in its pipeline....

Shire Gets Breakthrough Therapy Designation For SHP621 And SHP625

Monday broker round-up

(ShareCast News) - Wolseley: JP Morgan reiterates neutral with a target price of 4100p. Cairn Energy: RBC reiterates sector perform with a 250p target...

BROKER RATINGS SUMMARY: JPMorgan Downgrades Wolseley To Neutral

WINNERS & LOSERS SUMMARY: BP Rises After Settling Gulf Oil Spill Claim

Shire completes combination with Baxalta

(ShareCast News) - Irish pharmaceuticals company Shire said on Friday that it has completed its $32bn takeover of US-based Baxalta. Shire said that it...